Ghent University Academic Bibliography

Your filters: cql: parent exact "Multiple Sclerosis Journal"

Add to list
- Journal Article
- A1
- open access
Managing reactivation of multiple sclerosis during treatment with natalizumab

Nathaniel Lizak, Sifat Sharmin, Dana Horáková, Eva Kubala Havrdova, Sara Eichau, Anneke van der Walt, Helmut Butzkueven, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, et al.

(2025) MULTIPLE SCLEROSIS JOURNAL. 32(1). p.121-133
Add to list
- Journal Article
- A1
- open access
Four years on : pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, Sara Eichau, Stella Hughes, Barbara Willekens, Dana Horakova, Eva Kubala Havrdova, Serkan Ozakbas, Cavit Boz, et al.

(2025) MULTIPLE SCLEROSIS JOURNAL. 31(9). p.1088-1101
Add to list
- Journal Article
- A1
- open access
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Suzanne Hodgkinson, Raed Alroughani, Sara Eichau Madueño, Cavit Boz, Anneke van der Walt, et al.

(2024) MULTIPLE SCLEROSIS JOURNAL. 30(9). p.1163-1175
Add to list
- Journal Article
- A1
- open access
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis : results from MSBase registry

T Spelman, S Ozakbas, R Alroughani, M Terzi, S Hodgkinson, Guy Laureys (UGent) , T Kalincik, A Van Der Walt, B Yamout, J Lechner-Scott, et al.

(2023) MULTIPLE SCLEROSIS JOURNAL. 29(2). p.221-235
Add to list
Comparative effectiveness in multiple sclerosis : a methodological comparison

Izanne Roos, Ibrahima Diouf, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, et al.

(2023) MULTIPLE SCLEROSIS JOURNAL. 29(3). p.326-332
Add to list
- Journal Article
- A1
- open access
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

C Daruwalla, V Shaygannejad, S Ozakbas, EK Havrdova, D Horakova, R Alroughani, C Boz, F Patti, M Onofrj, A Lugaresi, et al.

(2023) MULTIPLE SCLEROSIS JOURNAL. 29(7). p.875-883
Add to list
- Conference Paper
- C3
Pilot study : vagus nerve stimulation reduces microglia around a demyelinating lesion in a lysolecithin-induced demyelination model

Helen Bachmann (UGent) , S Vandenabeele, Lars Emil Larsen (UGent) , Evelien Carrette (UGent) , Wytse Wadman (UGent) , Jean Delbeke (UGent) , Kristl Vonck (UGent) , Paul Boon (UGent) , Robrecht Raedt (UGent) and Guy Laureys (UGent)

(2022) MULTIPLE SCLEROSIS JOURNAL. In Multiple Sclerosis Journal 28(3, Supplement). p.608-609
Add to list
Application of step and beat alignment approaches and its effect on gait in progressive multiple sclerosis with severe cerebellar ataxia : a proof of concept case study

Lousin Moumddjian (UGent) , Bart Moens (UGent) , Bart Van Wijmeersh, Marc Leman (UGent) and Peter Feys

(2022) MULTIPLE SCLEROSIS JOURNAL. 28(3). p.492-495
Add to list
Prediction of multiple sclerosis outcomes when switching to ocrelizumab

Michael Zhong, Anneke van der Walt, Jim Stankovich, Tomas Kalincik, Katherine Buzzard, Olga Skibina, Cavit Boz, Suzanne Hodgkinson, Mark Slee, Jeannette Lechner-Scott, et al.

(2022) MULTIPLE SCLEROSIS JOURNAL. 28(6). p.958-969
Add to list
- Conference Paper
- C3
Embodied learning in persons with Multiple Sclerosis using melodic, sound and visual real-time feedback : a potential approach towards rehabilitation

Lousin Moumddjian (UGent) , Joren Six (UGent) , Renee Veldkamp, Jenke Geys, Channa Van Der Linden, Mieke Goetschalckx, Johan Van Nieuwenhoven, Ilse Bosmans, Marc Leman (UGent) and Peter Feys

(2021) RIMS Annual Conference. In MULTIPLE SCLEROSIS JOURNAL 27(suppl. 3). p.22-22

Academic Bibliography

Managing reactivation of multiple sclerosis during treatment with natalizumab

Four years on : pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis : results from MSBase registry

Comparative effectiveness in multiple sclerosis : a methodological comparison

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

Pilot study : vagus nerve stimulation reduces microglia around a demyelinating lesion in a lysolecithin-induced demyelination model

Application of step and beat alignment approaches and its effect on gait in progressive multiple sclerosis with severe cerebellar ataxia : a proof of concept case study

Prediction of multiple sclerosis outcomes when switching to ocrelizumab

Embodied learning in persons with Multiple Sclerosis using melodic, sound and visual real-time feedback : a potential approach towards rehabilitation

Contents

Support

Contact